RIGL: Rigel Pharmaceuticals O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Rigel Pharmaceuticals (RIGL) onkologiya va qon kasalliklariga qarshi kurashish uchun maqsadli terapiyalarni ishlab chiqadi. O'sish aksiyalarining jozibadorlik ko'rsatkichi ushbu ishlanmalarni hematologlar va sug'urta fondlari tomonidan ta'minlanadigan trombotsitopeniya davolanishidan tushadigan daromadlar bilan bog'laydi. Ommaviy dori sotuvlariga o'tish biznes marjalarini kengaytirmoqda, shu bilan birga ko'rsatkich 0.00 atrofida saqlanib qolgan holda kompaniyaning adolatli qiymatini aniqlashga yordam bermoqda.
Rigel Pharmaceuticals (RIGL) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Rigel Pharmaceuticals|RIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi rigel.com|RIGL - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Rigel Pharmaceuticals Inc|RIGL - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Rigel Pharmaceuticals|Oraliq qoplama koeffitsiyenti rigel.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
RIGL - Sof foyda|Prognoz qilingan sof foyda Rigel Pharmaceuticals|RIGL - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Rigel Corp|RIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Rigel Pharmaceuticals Inc|RIGL - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Rigel Pharmaceuticals|RIGL - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi rigel.com|RIGL - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Rigel Pharmaceuticals
Kompaniyaning umumiy tahlili:RIGL - Rigel Pharma
Kambag'allashgan aktivlarni aniqlash uchun investorlar P/E bozor koeffitsientini kutilayotgan foyda o'sishi bilan solishtirishlari kerak. Ushbu metrika kelajakdagi o'sishning bir birligi uchun xarajatni o'lchaydi, bunda birdan past qiymat potensial chegirmadan dalolat beradi, bu esa Rigel Pharmaceuticals (RIGL) kompaniyasining onkologiya sohasidagi benuqson obro'si bilan birgalikda, tarixiy PEG koeffitsiyenti orqali biznesning bozor tebranishlariga chidamliligini baholash imkonini beradi.
Rigel Pharmaceuticals raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PHVS (Pharvaris Pharma)|ABCL: PEG multiplikatori|TRML - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PGEN (Precigen) - PEG multiplikatori|PHAR - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori NKTR|UPB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PVLA (Pieris Corp)|SVRA (Savara Inc.) - PEG multiplikatori|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATXS|PEG multiplikatori enGene Holdings Inc (ENGN)|Narxning foydaga va o‘sish sur’atiga nisbati RAPT Therapeutics, Inc. RAPT|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti JBIO|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|kyvernatx.com (KYTX) - Narx-foyda va o‘sish multiplikatori|TLSA: PEG multiplikatori|Cabaletta Bio Inc. (CABA) - PEG multiplikatori|VTYX (Ventyx Bio) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Theratechnologies, Inc (THTX)|PEG multiplikatori AVTX|ELDN - O‘sish sur’atiga tuzatilgan narx-foyda|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Climb Bio Inc. CLYM|ZURA: Narx-foyda va o‘sish multiplikatori|aTyr Pharmaceuticals - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ADAG: PEG multiplikatori|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|STTK (Shattuck Labs Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Equillium Bio (EQ)|PEG multiplikatori CNTB|PEG multiplikatori immunic-therapeutics.com (IMUX)|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|InflaRx NV - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Adicet Bio ACET|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|kezarlifesciences.com (KZR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori SABS|Akari Therapeutics PLC (AKTX) - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|Q32 Bio Inc - Narxning foydaga va o‘sish sur’atiga nisbati|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati EDSA|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
